Former Southeast Radiology physicians Lance Becker, MD, Kurt Muetterties, MD, and Chad Brecher, MD
Source
SRL
Southeast Radiology Ltd., in the Philadelphia suburb of Upland, ceased existing at the end of June as it grappled with physician shortages, increased competition, "considerable instability" and market disruption.
Among general cardiologists, compensation increased nearly 8% from 2023 to 2024. Interventional cardiology and electrophysiology saw even larger jumps.
Morphic's new treatment for inflammatory bowel disease is in Phase II clinical trials and shows promise in improving patient outcomes. Eli Lilly will purchase the company for $57 per share in cash.
Although great strides have been made in promoting equity, inclusion and diversity in radiology, academic settings still lack adequate representation, according to a new study.
The Acurate neo2 aortic valve system. Image courtesy of Boston Scientific.
The self-expanding valve is not yet approved by the FDA, but care teams in other markets are reporting positive outcomes when patients go home the day after treatment.
Quantification results of mean LV and RV volumes of automated four-chamber and short-axis segmentation methods over time. a AI-generated contours of short-axis cine stack of images using standard endocardial and epicardial contour methods. b AI-generated four-chamber cine segmentation contours using standard endocardial and epicardial contours methods. c AI-generated four-chamber cine segmentation results yielded slightly lower LV and RV volumes than the ground truth. d Quantification results of automated four-chamber mean LV and RV volumes after applying 14.56 mL and 50.78 mL correction factors and short-axis segmentation results over time. Images/caption courtesy of European Radiology Experimental.
New data out of England provides cardiologists and radiologists with another reminder of AI's potential to transform healthcare.
"The failure of CMS to make virtual supervision permanent is certainly disappointing,” attorney and radiology policy expert Tom Greeson wrote Thursday.
For years, the agency has packaged payment for nuclear imaging agents with the procedure, but this has created a barrier for those who require pricier new drugs.
